[ Price : $8.95]
A Reuters deep dive into HHS secretary Robert F. Kennedy Jr.s efforts to eliminate childhood vaccine requirements says his aides a...[ Price : $8.95]
FDA grants Roche a priority review for its supplemental BLA seeking approval for Gazyva (obinutuzumab) for treating adults with pr...[ Price : $8.95]
FDA accepts for review an Axsome Therapeutics NDA for AXS-12 (reboxetine) for treating cataplexy in patients with narcolepsy.[ Price : $8.95]
Neurelis petitions FDA to ensure that any generic version of diazepam nasal spray is no less safe and effective than its Valtoco f...[ Price : $8.95]
House Energy and Commerce Committee ranking member Frank Pallone asks the Government Accountability Office to analyze how FDA paid...[ Price : $8.95]
A group of academic and public health experts urges FDA to embrace greater transparency, scientific independence and regulatory co...[ Price : $8.95]
FDA converts the accelerated approval of Eli Lilly's Retevmo (selpercatinib) into a traditional approval for treating adult and pe...[ Price : $8.95]
FDA warns South El Monte, CA-based International Medication Systems about CGMP violations in its production of finished drugs.